Spravato® is an FDA-approved breakthrough treatment for treatment resistant major depressive disorder (TRD) in adults. It is an intranasal medicine, prescribed along with an oral antidepressant.
Clinical trials have shown over 60% response rate, and 52% remission rate in patients treated with Spravato® with minimal side effects.
Spravato® is FDA-approved to treat two specific types of depression in adults:
Treatment-Resistant Depression (TRD) Treatment-resistant depression is depression that does not improve with two or more antidepressants tried at adequate dosages and duration.
Major Depressive Disorder with Suicidal Ideations If you have major depressive disorder and have expressed suicidal thoughts or behaviors, Our spravato® nasal spray in Plano may be an appropriate next step in treatment.